These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 20215064

  • 1. Gastrointestinal and hepatic complications of sickle cell disease.
    Ebert EC, Nagar M, Hagspiel KD.
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):483-9; quiz e70. PubMed ID: 20215064
    [Abstract] [Full Text] [Related]

  • 2. Gastrointestinal pathology in sickle cell disease.
    Krauss JS, Freant LJ, Lee JR.
    Ann Clin Lab Sci; 1998 Jun; 28(1):19-23. PubMed ID: 9512780
    [Abstract] [Full Text] [Related]

  • 3. [Management of sickle cell disease].
    de Montalembert M.
    Rev Prat; 2004 Sep 30; 54(14):1557-64. PubMed ID: 15558966
    [Abstract] [Full Text] [Related]

  • 4. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA, Adly AA, Ismail EA, Darwish YW, Ali Zedan M.
    Blood Cells Mol Dis; 2014 Dec 30; 53(4):189-93. PubMed ID: 25065856
    [Abstract] [Full Text] [Related]

  • 5. Hydroxyurea in the treatment of sickle-cell anemia.
    Howard LW, Kennedy LD.
    Ann Pharmacother; 1997 Nov 30; 31(11):1393-6. PubMed ID: 9391697
    [Abstract] [Full Text] [Related]

  • 6. Sickle cell disease; a general overview.
    Schnog JB, Duits AJ, Muskiet FA, ten Cate H, Rojer RA, Brandjes DP.
    Neth J Med; 2004 Nov 30; 62(10):364-74. PubMed ID: 15683091
    [Abstract] [Full Text] [Related]

  • 7. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N.
    Pediatr Nurs; 2006 Nov 30; 32(6):541-3. PubMed ID: 17256291
    [Abstract] [Full Text] [Related]

  • 8. Transfusion-related chronic liver disease in sickle cell anemia.
    Comer GM, Ozick LA, Sachdev RK, Kumar S, Taunk JL, Smith JA, Lee TP, Clain DJ.
    Am J Gastroenterol; 1991 Sep 30; 86(9):1232-4. PubMed ID: 1882802
    [Abstract] [Full Text] [Related]

  • 9. Ten-year review of hospital admissions among children with sickle cell disease in Kuwait.
    Akar NA, Adekile A.
    Med Princ Pract; 2008 Sep 30; 17(5):404-8. PubMed ID: 18685282
    [Abstract] [Full Text] [Related]

  • 10. [Pathophysiology and treatment of sickle-cell disease].
    van Beers EJ, Peters M, Biemond BJ.
    Ned Tijdschr Geneeskd; 2005 May 21; 149(21):1144-9. PubMed ID: 15940917
    [Abstract] [Full Text] [Related]

  • 11. Sickle cell diseases: What can nuclear medicine offer?
    Niccoli Asabella A, Altini C, Nappi AG, Lavelli V, Ferrari C, Marzullo A, Loiodice A, Rubini G.
    Hell J Nucl Med; 2019 May 21; 22(1):2-3. PubMed ID: 30843001
    [Abstract] [Full Text] [Related]

  • 12. Serum apelin as a novel non-invasive marker for subclinical cardiopulmonary complications in children and adolescents with sickle cell disease.
    Elbarbary NS, Ismail EA, Roushdy A, Fahmy E.
    Blood Cells Mol Dis; 2016 Mar 21; 57():1-7. PubMed ID: 26852648
    [Abstract] [Full Text] [Related]

  • 13. Approach to the vaso-occlusive crisis in adults with sickle cell disease.
    Yale SH, Nagib N, Guthrie T.
    Am Fam Physician; 2000 Mar 01; 61(5):1349-56, 1363-4. PubMed ID: 10735342
    [Abstract] [Full Text] [Related]

  • 14. Blood transfusion in sickle cell disease.
    Marouf R.
    Hemoglobin; 2011 Mar 01; 35(5-6):495-502. PubMed ID: 21981466
    [Abstract] [Full Text] [Related]

  • 15. Indications and complications of splenectomy for children with sickle cell disease.
    Al-Salem AH.
    J Pediatr Surg; 2006 Nov 01; 41(11):1909-15. PubMed ID: 17101369
    [Abstract] [Full Text] [Related]

  • 16. New advances in the treatment of sickle cell disease: focus on perioperative significance.
    Dix HM.
    AANA J; 2001 Aug 01; 69(4):281-6. PubMed ID: 11759366
    [Abstract] [Full Text] [Related]

  • 17. Sickle cell disease: role of reactive oxygen and nitrogen metabolites.
    Wood KC, Granger DN.
    Clin Exp Pharmacol Physiol; 2007 Sep 01; 34(9):926-32. PubMed ID: 17645642
    [Abstract] [Full Text] [Related]

  • 18. [Effect of hydroxyurea on hemoglobin S].
    Torres AF, Eberle SE, Sciuccati G, Bonduel M.
    Medicina (B Aires); 2003 Sep 01; 63(2):140-2. PubMed ID: 12793083
    [Abstract] [Full Text] [Related]

  • 19. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A, Fink D, Admoni O, Tennenbaum-Rakover Y, Levin C.
    Eur J Haematol; 2010 Jan 01; 84(1):72-8. PubMed ID: 19732137
    [Abstract] [Full Text] [Related]

  • 20. Sickle cell disease in North Europe.
    Howard J, Davies SC.
    Scand J Clin Lab Invest; 2007 Jan 01; 67(1):27-38. PubMed ID: 17365983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.